What is Applied BioCode?
Applied BioCode operates as a specialized manufacturer in the in-vitro diagnostics (IVD) sector, focusing on the development and commercialization of multiplex testing products. The company's core value proposition lies in its ability to provide comprehensive assay panels for gastrointestinal and respiratory pathogens, supported by proprietary instrumentation designed to optimize laboratory throughput. By integrating advanced detection technologies, Applied BioCode enables clinical and research laboratories to achieve higher operational efficiency while maintaining rigorous diagnostic standards. Their market position is defined by a commitment to innovation in infectious disease diagnostics, ensuring that healthcare providers have access to rapid, simultaneous pathogen detection tools that are essential for modern clinical workflows.
How much funding has Applied BioCode raised?
Applied BioCode has raised a total of $9.6M across 2 funding rounds:
Private Equity
$9.3M
Debt
$350K
Private Equity (2014): $9.3M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in Applied BioCode
PPP
Public-Private Partnership
Undisclosed Investor
A private equity participant providing foundational capital to support long-term growth and market expansion.
What's next for Applied BioCode?
With the recent influx of capital, Applied BioCode is well-positioned to accelerate its enterprise-level growth strategy. The focus will likely shift toward expanding the commercial footprint of its multiplex assay portfolio and enhancing the technical capabilities of its diagnostic instruments. As the demand for high-throughput, accurate testing continues to rise, the company is expected to prioritize R&D initiatives that further reduce turnaround times and improve diagnostic precision. Strategic scaling will be critical as the firm navigates the competitive IVD landscape, aiming to solidify its role as a primary provider for large-scale clinical laboratories seeking to modernize their infectious disease testing capabilities.
See full Applied BioCode company page
